STOCK TITAN

VERU S-3 Filings

VERU NASDAQ

Here are the S-3 shelf registrations from Veru Inc. (VERU) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An S-3 covers the shelf registration that lets an established company sell over time, so if you follow VERU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VERU filings page.

Rhea-AI Summary

Veru Inc. registers up to $200,000,000 of common stock, debt securities, preferred stock, warrants, purchase contracts, rights and units from time to time under a shelf registration.

This prospectus provides a general description of the securities and states that specific terms, offering price and net proceeds will be set forth in a prospectus supplement. The offering is subject to completion and effectiveness and may be sold directly, through agents, dealers, or underwriters.

Rhea-AI Summary

Veru Inc. filed a Registration Statement on Form S-3 to register 23,800,000 shares of common stock issuable upon exercise of warrants issued under a prospectus supplement dated October 29, 2025. The warrants consist of pre-funded warrants for 7,000,000 shares (exercise price $0.001), Series A warrants for 8,400,000 shares (exercise price $3.00) and Series B warrants for 8,400,000 shares (exercise price $3.00).

The pre-funded warrants are immediately exercisable with no expiration, Series A warrants expire five years from issuance, and Series B warrants expire upon the earlier of the third anniversary of issuance or certain clinical-data and trading-price triggers described in the prospectus. If all warrants are exercised for cash, aggregate proceeds to Veru would be approximately $50,407,000.